Skip to main content
Caplight Logo









Amazentis

Amazentis

Private
LausanneHealthcare & Life Scienceshttps://www.timeline.com/

Last Round

Grant

May 19, 2025

Total Funding Raised

$87.36M

Company Overview

Amazentis is a biotechnology company that develops nutritional and skincare products to combat aging and improve quality of life.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, D2C Brands, Fashion & Beauty

Business Model

B2C

Customer Profile

Subscription SaaS, Hardware Sales

AI Layer

Application

Keywords

mitochondrial healthlongevityUrolithin AMitopuremitophagybiohackingnutritional supplementscellular wellnessanti-agingmuscle healthbiotechnologyDTC supplementsskincarehealthspanskin health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Amazentis Comparables

Compare Amazentis with similar companies based on industry and business-model similarity.

Amazentis comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MitoQ
88%
Elysium Health
83%
NOVOS
80%

Amazentis Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 19, 2025
Series DJan 17, 2024
Series BSep 25, 2023
Corporate FundingApr 2, 2019
Series CMar 21, 2018

Amazentis Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 19, 2025

    Secured $250K in grant funding.

  • May 12, 2025

    Recognized as a Top 40 global team for innovative approaches.

Amazentis Filings

Explore SEC and related filing metadata, where available.

Amazentis filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Amazentis's valuation, stock price, and market status.

Is Amazentis a public or private company?

Amazentis is a private company.

What is the current stock price of Amazentis?

Amazentis is a private company with no public stock price. No recent secondary market data is available.

How much is Amazentis worth (valuation)?

Valuation information for Amazentis is not publicly available.

Can I buy Amazentis stock?

Amazentis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Amazentis's last funding round?

Amazentis's most recent funding round was Grant on May 19, 2025.

Who are the main investors in Amazentis?

Key investors in Amazentis include BlackFin Capital Partners, BOLD (Business Opportunities for L'Oréal Development).

Will Amazentis IPO soon?

No public IPO plans have been announced for Amazentis.

How can I track Amazentis secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Amazentis's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLausanne
Employee Range74
Year Founded2007
Last FundingMay 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?